Imaging-based characterisation of pathogen activity and host-cell injury for defence, biosecurity and biopharma.
Imaging-based characterisation of pathogen activity and host-cell injury for defence, biosecurity and biopharma.
DefenSight provides sovereign, auditable biological‑effects analytics for CBRN and biosecurity missions. We convert microscopy imaging into defensible, operator‑independent intelligence that shows whether a biological agent is active, replicating, and causing harm, not just present.
Our platform shortens the time from detection to assessment to action, supporting mission‑level decision‑making in high‑consequence environments.
Interpretable ML. Sovereign IP. Defence‑aligned.
We quantify pathogen activity and host‑cell injury with per‑cell, sub‑200 nm resolution, across 96/384/1536‑well plates and high‑resolution imaging systems. Outputs are reproducible, interpretable, and audit‑ready, aligned with Defence and national preparedness needs.
1. Pilot analysis
Segmentation, per‑cell features, QC summary, CSV + plots/PDF. Tailored to your imaging hardware, biosafety constraints, and mission context.
2. Workflow stabilisation
SOP templates, controls, acceptance criteria, QC gates. Designed for reproducibility, governance, and operational reliability.
3. Interpretable ML
Versioned models, audit trails, uncertainty‑aware outputs. Human‑in‑the‑loop analytics that remain transparent and defensible.
“Detection tells you what is present. Our analytics tell you whether it is active and causing harm.”
Dr Sonja Frölich, Founder & Chief Scientist